Skip to content

Double Marker Test in India at ₹1,949 – Thyrocare

In association with Thyrocare NABL-Accredited Lab FMF-Certified Risk Assessment Tool Free Home Collection Pan-India Service

Double Marker (Dual Marker) Test by Thyrocare:

The Double Marker test, also called the Dual Marker test, is a first-trimester prenatal blood screening used to estimate the risk of chromosomal conditions such as Down syndrome and Edwards syndrome. It measures PAPP-A and free β-hCG, and the result is interpreted with gestational age details and the NT scan report. This test is performed between the 8th and 13th week of pregnancy.

Offer Price: ₹1,949 MRP: ₹2,500

Free home sample collection for a dual marker test is available in 200+ cities and towns across India.

Double Marker (Dual Marker) prenatal screening test by Thyrocare with free home sample collection.
Test nameDouble Marker – First-trimester pregnancy screening
Other names of the TestsDual markers, First-trimester maternal serum screening
Test TypeFirst-trimester prenatal screening
Offer Price₹1,949
What’s measuredFree β-hCG and Pregnancy-Associated Plasma Protein-A (PAPP-A); reported with MoM normalization
Testing PeriodBetween the 8th and 13th week of pregnancy
Sample typeBlood (serum)
Sample quantity4 ml
FastingNot required
Reporting timearound 48 hours after sample collection
Report formatBiomarker values (including MoM) and risk estimate output graph (in probability)
Testing LabThyrocare
Lab StandardCAP and NABL-accredited and ISO-certified
Test QualityUses FMF-certified biomarker testing kits and SSDW Lab 6 software for better accuracy

What’s Included in the Double Marker (Dual Marker) Test

Biomarkers

PAPP-A and free β-hCG from a single blood sample.

Risk calculation

The biomarker values are interpreted with gestational age and relevant maternal details to generate the screening risk estimate.

Screening output graph

Provides a risk probability, such as high-risk, medium-risk, or low-risk

Preparation for A Double Marker Test Profile

  • Fasting: Not required. Stay well-hydrated.
  • Gestational age (GA): Share your last menstrual period (LMP) to calculate GA.
  • Documents: Keep the test requisition form (TRF) and the NT scan report ready. These help confirm whether the required screening is a double marker, triple marker, or quadruple marker test.
  • Clinical context: Mention all required context, including pregnancy type (twin /ART/IVF), pregnancy history (number of children and miscarriage history, if any), and whether diabetic or not, so the lab pathway can be applied appropriately.
  • Habits: Mention smoking or alcohol use, if any, because these details are relevant to risk interpretation.
  • DOB: Provide the correct date of birth, because age is part of the risk calculation.

How to Book the Double Marker Test

  1. Send your city name or area pin code on WhatsApp so we can confirm coverage and the earliest slot.
  2. Share the beneficiary’s name, age, gender, complete address, contact details, and preferred date and time of sample collection.
  3. Sample collection will be performed on time by a trained phlebotomist.
  4. Provide the required information (correct DOB, weight, pregnancy history and type, clinical history, and habit) and a copy of the NT scan report to the phlebotomist.
  5. Receive your report via email/WhatsApp within the expected turnaround time.

Book Now, Pay During the Sample Collection

Sample report of the Double Marker Test

A sample FMF-certified Double Marker report graph is shown below.

FMF-certified Dual Marker graph report.

To view a sample of the complete report, including biomarker values, the graph, and the final risk assessment, use the link below.

Why a Double Marker Test Is Advised in Pregnancy

The Double Marker test is used in the first trimester to screen for the risk of certain chromosomal conditions. It is advised, along with an NT scan, when early pregnancy risk assessment is needed.

This screening does not give a final diagnosis. It helps identify whether the pregnancy falls into a lower-risk or higher-risk category and whether further evaluation may be needed.

Limitation of a Double Marker Test Panel

  • The Double Marker test is a screening test; it does not confirm or rule out a chromosomal condition.
  • In triplet pregnancy, the Double Marker risk assessment is not possible. In twin pregnancy, risk estimation may be less accurate.
  • After 13 weeks and 6 days of pregnancy, Double Marker risk estimation is not possible. In such a case, a triple marker or quadruple marker test is suggested, depending on the clinical context.
  • Incorrect information in the test requisition form or patient details can affect risk calculation.
  • If the report shows high risk, your obstetrician may advise follow-up options such as NIPT or amniocentesis.

Browse Related Prenatal and Women’s Health Panels

Prenatal & Antenatal Screening

Browse related screening profiles and booking options.

TORCH Panel Tests

Infection screening panel.

Women’s Health Profile

Find ranges of health screening profiles for females.

FAQs on Double Marker Test by Thyrocare

What is the price of the Double Marker test?
The offer price is ₹1,949. It is discounted from MRP ₹2,500.
Is fasting required for the Double Marker test?
No, fasting is not required for this blood test.
When is the Double Marker test performed?
It is performed in the first trimester, between the 8th and 13th week of pregnancy.
Do I need an NT scan for Double Marker screening?
Yes, an NT scan report is mandatory for a double marker test.
What does a “high-risk” result mean?
A high-risk result indicates a higher probability, not a diagnosis. Your clinician may advise genetic counseling and confirmatory options such as NIPT or amniocentesis, based on your overall clinical context.
How soon will I receive my report?
The reporting time is around 48 hours after sample collection, although timing can slightly vary by city and logistics.
Is home sample collection available across India?
Home sample collection is available in 200+ cities and towns in India through Thyrocare networks. Slot availability and coverage depend on your location.

Important: This is a screening test. Decisions and follow-ups should be made with your obstetrician/fetal medicine specialist.

Written by: Hema Mehta Sahoo
Medically reviewed by: Dr. M A Khan, MBBS, MD Pathology
Last updated: March 24, 2026

References (For Reading)